0 NASDAQ Companies - September 17, 2019Galectin Therapeutics, Inc. and Providence Cancer Institute Receive Patent on the Use of Belapectin (GR-MD-02) in Cancer ImmunotherapyRead More
0 NASDAQ Companies - September 17, 2019Immutep Announces Japanese Patent Grant for LAG525 AntibodyRead More
0 NASDAQ Companies - September 17, 2019Tyme Technologies to Present at the Ladenburg Thalmann 2019 Healthcare Conference on September 24, 2019Read More
0 NASDAQ Companies - September 17, 2019Centrexion Therapeutics Announces Completion of Patient Enrollment in VICTORY-3 Phase 3 Open-Label Clinical Trial of CNTX-4975 in Patients with Moderate-to-Severe Osteoarthritis Knee PainRead More
0 NASDAQ Companies - September 17, 2019Avalo Networks Provides Next-Generation Voice Services and Grows with Ubersmith Business Management SoftwareRead More
0 NASDAQ Companies - September 17, 2019Yale Cancer Center to Present on the Synergistic Relationship Between Intravenously-Administered SB 11285, Spring Bank’s STING Agonist Development Compound, and Radiation Therapy in Cancer at the 2019 ASTRO Annual MeetingRead More
0 NASDAQ Companies - September 17, 2019Talend Launches New Cloud Accreditation Program for PartnersRead More
0 TSX Venture News - September 17, 2019Petroteq Announces Commissioning of Asphalt Ridge FacilityRead More
0 TSX Venture News - September 17, 2019Kutcho Copper Files Project Description and Enters into Environmental Assessment and Permitting ProcessRead More
0 TSX Venture News - September 17, 2019LexaGene Develops Test for Deadly Mosquito-borne EEE VirusRead More
